WELACTO is a gentle osmotic laxative syrup designed for effective management of constipation by increasing water content in the colon and facilitating easier bowel evacuation. It can be useful for patients requiring a gradual, stool-softening approach and offers convenient liquid administration within the PCD Pharma Gastro & Laxative portfolio.
Constipation and, at appropriate doses, hepatic encephalopathy.
Yes, by increasing water content in the bowel.
Maintain adequate fluid intake unless restricted. Dose should be individualized according to response. Excessive use may cause diarrhea and electrolyte imbalance.
Bloating, abdominal cramps, flatulence, nausea and diarrhea may occur, especially at higher doses.
WELACTO: Lactulose is metabolized by colonic bacteria into organic acids that increase osmotic water retention in the bowel, softening stool and promoting bowel movement.
